Detection of Major Histocompatibility Complex/Human Cartilage gp-39 Complexes in Rheumatoid Arthritis Synovitis as a Specific and Independent Histologic Marker

Arthritis and Rheumatism

Volumn 50, Issue 2, 2004, Pages 444-451

  Baeten, Dominique ^a   Steenbakkers, Peter G A ^b   Rijnders, Antonius M W ^b   Boots, Annemieke M ^b   Veys, Eric M ^a   De Keyser, Filip ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b NV ORGANON   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD3 ANTIGEN; EPITOPE; GLYCOPROTEIN GP 39; HLA DR4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 12A; PEPTIDE DERIVATIVE; T6 ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNE DISEASE; CHRONIC INFLAMMATION; CONTROLLED STUDY; DENDRITIC CELL; DISEASE MARKER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; LYMPHOID ORGAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVITIS; SYNOVIUM; T LYMPHOCYTE;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; AUTOANTIGENS; BIOLOGICAL MARKERS; CARTILAGE, ARTICULAR; DENDRITIC CELLS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLYCOPROTEINS; HLA-DR4 ANTIGEN; HUMANS; IMMUNOENZYME TECHNIQUES; KNEE JOINT; MALE; MIDDLE AGED; SINGLE-BLIND METHOD; STAINING AND LABELING; SYNOVIAL MEMBRANE; SYNOVITIS;

EID: 1042278741     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20012     Document Type: Article

References (27)

1. Torchilin VP, Iakoubov LZ, Estrov Z. Antinuclear autoantibodies as potential antineoplastic agents. Trends Immunol 2001;22:424-7.
2. Watanabe H, Inaba M, Adachi Y, Sugiura K, Hisha H, Iguchi T, et al. Experimental autoimmune thyroiditis induced by thyroglobulin-pulsed dendritic cells. Autoimmunity 1999;31:273-82.
3. Falcone M, Yeung B, Tucker L, Rodriguez E, Krahl T, Sarvetnick N. IL-4 triggers autoimmune diabetes by increasing self-antigen presentation within the pancreatic islets. Clin Immunol 2001;98:190-9.
4. Weir CR, Nicolson K, Backstrom BT. Experimental autoimmune encephalomyelitis induction in naive mice by dendritic cells presenting a self-peptide. Immunol Cell Biol 2002;80:14-20.
5. Ludewig B, Junt T, Hentgartner H, Zinkernagel RM. Dendritic cells in autoimmune diseases. Curr Opin Immunol 2001;13:657-62.
6. Wu Q, Salamon B, Chen M, Wang Y, Hoffman LM, Bluestone JA, et al. Reversal of spontaneous autoimmune insulitis in nonobese diabetic mice by soluble lymphotoxin receptor. J Exp Med 2001;193:1327-32.
7. Thomas R, MacDonald KP, Pettit AR, Cavanagh LL, Padmanabha J, Zehntner S. Dendritic cells and the pathogenesis of rheumatoid arthritis. J Leukoc Biol 1999;66:286-92.
8. Verheijden GF, Rijnders AW, Bos E, Coenen-de Roo CJ, van Staveren CJ, Miltenburg AM, et al. Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis. Arthritis Rheum 1997;40:1115-25.
9. Baeten D, Boots AMH, Steenbakkers PGA, Elewaut D, Bos E, Verheijden GFM, et al. Human cartilage gp-39+,CD16+ monocytes in peripheral blood and synovium: correlation with joint destruction in rheumatoid arthritis. Arthritis Rheum 2000;43:1233-43.
10. Pettit AR, Ahern MJ, Zehntner S, Smith MD, Thomas R. Comparison of differentiated dendritic cell infiltration of autoimmune and osteoarthritis synovial tissue. Arthritis Rheum 2001;44:105-10.
11. Page G, Lebecque S, Miossec P. Anatomic localization of immature and mature dendritic cells in an ectopic lymphoid organ: correlation with selective chemokine expression in rheumatoid synovium. J Immunol 2002;168:5333-41.
12. Steenbakkers PG, Baeten D, Rovers E, Veys EM, Rijnders AM, Meijerink J, et al. Localization of MHC class II/human cartilage glycoprotein-39 complexes in synovia of rheumatoid arthritis patients using complex-specific monoclonal antibodies. J Immunol 2003;170:5719-27.
13. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
14. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, et al, and the European Spondylarthropathy Study Group. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-30.
15. Baeten D, Van den Bosch F, Elewaut D, Stuer A, Veys EM, De Keyser F. Needle arthroscopy of the knee with synovial biopsy sampling: technical experience in 150 patients. Clin Rheumatol 1999;18:434-41.
16. Baeten D, Peene I, Union A, Meheus L, Sebbag M, Serre Guy, et al. Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies. Arthritis Rheum 2001;44:2255-62.
17. Joosten LA, Coenen-de Roo CJ, Helsen MM, Lubberts E, Boots AM, van den Berg WB, et al. Induction of tolerance with intranasal administration of human cartilage gp-39 in DBA/1 mice: amelioration of clinical, histologic, and radiologic signs of type II collagen-induced arthritis. Arthritis Rheum 2000;43:645-55.
18. Cope AP, Patel SD, Hall F, Congia M, Hubers HA, Verheijden GF, et al. T cell responses to a human cartilage autoantigen in the context of rheumatoid arthritis-associated and nonassociated HLA-DR4 alleles. Arthritis Rheum 1999;42:1497-507.
19. Hakala BE, White C, Recklies AD. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 1993;268:25803-10.
20. Vos K, Miltenburg AM, van Meijgaarden KE, van den Heuvel M, Elferink DG, van Galen PJ, et al. Cellular immune response to human cartilage glycoprotein-39 (HC gp-39)-derived peptides in rheumatoid arthritis and other inflammatory conditions. Rheumatology 2000;39:1326-31.
21. Tsark EC, Wang W, Teng Y-C, Arkfeld D, Dodge GR, Kovats S. Differential MHC class II-mediated presentation of rheumatoid arthritis autoantigens by human dendritic cells and macrophages. J Immunol 2002;169:6625-33.
22. Patil NS, Hall FC, Drover S, Spurrell DR, Bos E, Cope AP, et al. Autoantigenic HC gp39 epitopes are presented by the HLA-DM-dependent presentation pathway in human B cells. J Immunol 2001;166:33-41.
23. Klimiuk PA, Goronzy JJ, Bjornsson J, Beckenbaugh RD, Weyand CM. Tissue cytokine patterns distinguish variants of rheumatoid synovitis. Am J Pathol 1997;151:1311-9.
24. Vargas-Alarcon G, Londono JD, Hernandez-Pacheco G, Pacheco-Tena C, Castillo E, Cardiel MH, et al. Effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthropathies in Mexican patients. Ann Rheum Dis 2002;61:714-7.
25. Said-Nahal R, Miceli-Richard C, Gautreau C, Tamouza R, Borot N, Porcher R, et al. The role of HLA genes in familial spondyloarthropathy: a comprehensive study of 70 multiplex families. Ann Rheum Dis 2002;61:193-4.
26. Brown MA, Kennedy LG, Darke C, Gibson K, Pile KD, Shatford JE, et al. The effect of HLA-DR genes on susceptibility to and severity of ankylosing spondylitis. Arthritis Rheum 1998;41:460-5.
27. Kraan MC, Haringman JJ, Post WJ, Versendaal J, Breedveld FC, Tak PP. Immunohistological analysis of synovial tissue for differential diagnosis in early arthritis. Rheumatology 1999;38:1074-80.